November 8, 2016
DBV Technologies closes down phase II study of Viaskin Milk
DBV Technologies has completed the enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk
Pharmaceuticals, Biotechnology and Life Sciences
DBV Technologies has completed the enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk